Screening for Advanced Heart Failure Treatment (SEE-HF)

Abbott

Status: Completed

Conditions: CRT and/or ICD; Advanced Heart Failure

Study type: Observational

Funder types: Industry

Identifiers

NCT01626404

TC-060112

Details and patient eligibility

About

Advanced heart failure therapy (heart transplantation or LVAD) is underutilized and patients are underserved. The purpose of this prospective, observational study is to obtain multi-center data on the proportion of patients with CRT and/or ICD who are candidates for advanced heart failure treatment and obtain insights into patient and physician decisions regarding referral for advanced heart failure therapy.

Enrollment: 99 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• CRT and or ICD device in place.
• NYHA class III - IV heart failure
• EF </= 40%
• Patient is an out-patient
• Patient is on optimal medical management as tolerated and as defined by primary care physician.
• Patient has signed an informed consent for data collection.

Exclusion criteria

• Age <18 years or >80 years
• CRT device that has been implanted < 3 months prior to enrollment
• Coronary revascularization within 3 months prior to enrollment
• Patient only has ICD but has CRT planned
• Non-cardiac disease resulting in life expectancy < 2 yrs
• Patient is hospitalized or will be hospitalized at this time
• Known diagnosis of dementia
• Patient is currently on dialysis
• Oxygen dependent lung disease
• Previously or currently treated with LVAD or heart transplantation

Trial design

99 participants in 1 patient group

Patients enrolled

Description:

All patients enrolled in the study